Sarclisa Interactions
There are 240 drugs known to interact with Sarclisa (isatuximab), along with 1 disease interaction. Of the total drug interactions, 50 are major, and 190 are moderate.
- View all 240 medications that may interact with Sarclisa
- View Sarclisa disease interactions (1)
Most frequently checked interactions
View interaction reports for Sarclisa (isatuximab) and the medicines listed below.
- alpha-lipoic acid
- Ampyra (dalfampridine)
- Braftovi (encorafenib)
- Campath (alemtuzumab)
- Cytosar (cytarabine)
- Decadron (dexamethasone)
- dicyclomine
- doxylamine
- Eloxatin (oxaliplatin)
- Epogen (epoetin alfa)
- Erbitux (cetuximab)
- Fludara (fludarabine)
- idarubicin
- Imbruvica (ibrutinib)
- immune globulin oral
- irinotecan
- ivermectin
- Kyprolis (carfilzomib)
- Mektovi (binimetinib)
- melphalan
- Peganone (ethotoin)
- pegfilgrastim
- pirfenidone
- Pomalyst (pomalidomide)
- pyridoxine
- Rebinyn (coagulation factor ix)
- Rituxan Hycela (hyaluronidase / rituximab)
- solifenacin
- Tarceva (erlotinib)
- Tecfidera (dimethyl fumarate)
Sarclisa disease interactions
There is 1 disease interaction with Sarclisa (isatuximab) which include:
Report options
QR code containing a link to this page
More about Sarclisa (isatuximab)
- Sarclisa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD38 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
